REG - Kromek Group PLC - Result of AGM

KromekAnnouncement

13/12/2024 12:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241213:nRSM0769Qa&default-theme=true

RNS Number : 0769Q  Kromek Group PLC  13 December 2024

13 December 2024

 

Kromek Group plc

("Kromek" or the "Group")

 

Result of AGM

 

Kromek (AIM: KMK), a leading developer of radiation and bio-detection
technology solutions for the advanced imaging and CBRN detection segments,
announces that at its annual general meeting ("AGM"), held earlier today, all
resolutions were duly passed.

 

Details of the proxy voting results, which should be read alongside the Notice
of AGM, are below:

 

 Resolution  Votes for*                       Votes against                    Votes withheld  Total proxy votes
             No. of votes  % of votes cast**  No. of votes  % of votes cast**  No. of votes
 1           207,344,859   93.58              14,216,844    6.42               214,790         221,776,493
 2           219,607,384   99.44              1,240,099     0.56               929,010         221,776,493
 3           218,684,712   99.50              1,093,449     0.50               1,998,332       221,776,493
 4           219,546,698   99.64              784,563       0.36               1,445,232       221,776,493
 5           217,710,854   98.85              2,543,519     1.15               1,522,120       221,776,493
 6           202,085,251   91.31              19,229,668    8.69               670,309         221,985,228
 7           208,955,888   94.64              11,827,699    5.36               992,906         221,776,493

*Includes discretionary votes

**Excludes withheld votes

 

 

For further information, please contact:

 

 Kromek Group plc
 Arnab Basu, CEO                                                        +44 (0)1740 626 060

 Paul Farquhar, CFO

 Cavendish Capital Markets Limited (Nominated Adviser and Broker)        
 Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance            +44 (0)20 7220 0500

 Tim Redfern - ECM

 Michael Johnson/Tamar Cranford-Smith - Sales

 Gracechurch Group (Financial PR)
 Harry Chathli/Claire Norbury/Henry Gamble                              +44 (0)20 4582 3500

 

Kromek Group plc

 

Kromek Group plc is a leading developer of radiation detection and
bio-detection technology solutions for the advanced imaging and CBRN detection
segments. Headquartered in County Durham, UK, Kromek has manufacturing
operations in the UK and US, delivering on the vision of enhancing the quality
of life through innovative detection technology solutions.

 

The advanced imaging segment comprises the medical (including CT and SPECT),
security and industrial markets. Kromek provides its OEM customers with
detector components, based on its core cadmium zinc telluride (CZT) platform,
to enable better detection of diseases such as cancer and Alzheimer's,
contamination in industrial manufacture and explosives in aviation
settings.

 

In CBRN detection, the Group provides nuclear radiation detection solutions to
the global homeland defence and security market. Kromek's compact, handheld,
high-performance radiation detectors, based on advanced scintillation and
solid-state readout technology, are primarily used to protect critical
infrastructure, events, personnel and urban environments from the threat of
'dirty bombs'.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGEAAADFFNLFFA